Global API market is estimated to witness a growth rate of around 6.5% over the period of 2019–2025. Growing prevalence of chronic and acute diseases, growing focus on precision medicine, and surging biopharmaceutical industries across the globe are driving the global API market. According to the WHO, around 17.9 million fatalities occurred globally due to cardiovascular diseases (CVDs) in 2016, representing around 31% of global fatalities. Amongst these fatalities, around 7.4 million were due to coronary heart diseases (CHD) and nearly 6.7 million were due to stroke. By 2030, it has been projected that CVDs would be responsible for nearly 23.6 million mortalities across the globe. These facts and figures reflect the demand for various pharmaceuticals drugs, which in turn, augments the demand for APIs.
Request a free sample of our report on API Market: https://www.omrglobal.com/request-sample/api-market

The global API market is segmented on the basis of type, type of synthesis, manufacturer type, therapeutics, and region. On the basis of type, the market is divided into a generic API and branded API. The branded API segment is estimated to be the dominant segment over the forecast period. The growth of the branded segment is due to greater demand for patented drugs and their effectiveness as compared to generic drugs. On the basis of the type of synthesis, the market is classified into biotech API, synthetic API, and others. The synthetic API segment held the dominant position in the global API market in 2018. Furthermore, the market is classified on the basis of therapeutics into cardiovascular drugs, oncology drugs, neurology drugs, Non-steroidal Anti-inflammatory Drugs (NSAIDs), and others. NSAIDs therapeutics segment held the leading position in 2018.
A full report of API Market Is available at https://www.omrglobal.com/industry-reports/api-market

Global API Market Segmentation
By Type
General API
Branded API
By Type of Synthesis
Biotech API
Synthetic API
Others (High Potency API)
By Therapeutics
Cardiovascular Drugs
Oncology Drugs
Neurology Drugs
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Others (Orthopedic Drugs)
Regional Analysis
North America
US
Canada
Europe
UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
AbbVie Inc.
Aesica Pharmaceuticals, Ltd.
Almac group PLC
AstraZeneca PLC
Aurobindo Pharma Ltd.
Boehringer Ingelheim International GmbH
Cambrex Corp.
Cipla Ltd.
CordenPharma GmbH
EsteveQuímica, S.A.
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/api-market
About Us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404